The Best of ACC 2014
Certain topics presented at ACC 2014 are likely to have greater impact on patient care than others. Steven Nissen, MD, chairman of Cardiovascular Medicine at Cleveland Clinic, shares his top five choices.
Every year, cardiovascular physicians hope to leave the annual meeting of the American College of Cardiology (ACC) with information that improves their ability to provide optimal patient care. This year did not disappoint.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Amid the thousands of presentations, posters and discussions were clinical trial results that are game-changers. Some created excitement by confirming the value of new treatments and technologies, while helping define the populations that will benefit. Others disappointed by dashing hopes that certain medications, medical regimens or new techniques would solve long-standing problems.
Like other conference attendees, Steven Nissen, MD, chairman of Cardiovascular Medicine at Cleveland Clinic, felt certain topics are likely to have greater impact on patient care than others. His Top 5 picks from ACC 2014 include:
The biggest surprise, says Dr. Nissen, was renal denervation. “It demonstrates the power of self-delusion in medicine. A technique everyone thought would work produced no benefit.”
So what was his Number One choice? PCSK9 inhibitors—“the most powerful LDL-lowering therapy ever discovered. They also seem safe and effective in patients who can’t tolerate statins,” he says.